Timothy Page, MD
Ophthalmology · Birmingham, MINPI 1659365443
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $173,132 of the $250,000 with a category attached, or 69.3%. 18 manufacturers reported payments, led by Rxsight Inc at 34.1% of the total. Reporting peaked in 2022 at $114,630 and has fallen 67.3% since, to $37,428 in 2025. Among ophthalmology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 259 payments — averaging $965.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rxsight Inc$85K
- Bausch & Lomb Americas Inc.$77K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$57K
- Tarsus Pharmaceuticals, Inc.$13K
- Johnson & Johnson Surgical Vision, Inc.$6K
- Alcon$4K
- plus $9K from 12 others
Across 26 payments — averaging $2856.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch & Lomb Americas Inc.$26K
- Johnson & Johnson Surgical Vision, Inc.$25K
- Bausch Health US, LLC$23K
What the payments were for
- Consulting fees$173,13269%
- Speaking & faculty fees$27,85111%
- Travel & lodging$32,48713%
- Food & beverage$14,0116%
- Education$200%
- Charitable contribution$2,5001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rxsight Inc | 9 | $85,319 |
| Bausch & Lomb Americas Inc. | 87 | $76,982 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 86 | $56,547 |
| Tarsus Pharmaceuticals, Inc. | 26 | $12,537 |
| Johnson & Johnson Surgical Vision, Inc. | 15 | $5,942 |
| Alcon | 12 | $3,930 |
| Ophtec USA, Inc. | 2 | $3,200 |
| Microsurgical Technology, Inc. | 1 | $2,500 |
| Harrow Eye, LLC | 2 | $2,073 |
| Lensar, Inc. | 2 | $248 |
| Carl Zeiss Meditec USA, Inc. | 2 | $199 |
| AbbVie | 2 | $157 |
| NEW World Medical,inc. | 7 | $141 |
| Eyepoint US, Inc. | 1 | $121 |
| Kala Pharmaceuticals, Inc. | 2 | $32 |
| Sight Sciences, Inc. | 1 | $30 |
| Biotissue Holdings Inc. | 1 | $27 |
| Glaukos Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$83,400
- enVista MX60 IOL$66,694
- Crystalens Accommodating IOL (AT-52AO)$50,796
- Trulign IOL$39,240
- STELLARIS ELITE$35,914
- Akreos AO IOL$27,025
- STELLARIS$21,227
- STELLARIS PC$15,814
- CRYSTALENS$15,814
- AKREOS AO$15,814
- ENVISTA$15,814
- TRULIGN TORIC$15,814
- OPHTHALMIC INSTRUMENTS$9,955
- Catalys Laser System$4,675
- IC-8 Apthera IOL$3,160
- ENVISTA ENVY IOL$2,800
- ENVISTA TORIC$2,600
- VEVYE$2,000
- RXSIGHT CONTACT LENS$1,697
- RXSIGHT INJECTOR CARTRIDGE$1,697
How this compares
$250,000 in reported general payments places this provider in the 95th percentile of 674 ophthalmology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XdemvyLotilaner | 414 | $744,643 |
| RestasisCyclosporine | 42 | $52,273 |
| LumiganBimatoprost | 50 | $27,029 |
| ProlensaBromfenac Sodium | 64 | $21,887 |
| Bromfenac Sodium | 79 | $19,599 |
| Cyclosporine | 33 | $18,538 |
| Timolol Maleate | 192 | $18,159 |
| Prednisolone Acetate | 437 | $13,773 |
| Latanoprost | 491 | $10,429 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 30 | $6,769 |
| MoxifloxacinMoxifloxacin Hcl | 352 | $6,754 |
| Travoprost | 28 | $6,182 |
| Brimonidine Tartrate | 67 | $5,604 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 115 | $3,571 |
| Ketorolac Tromethamine | 151 | $3,498 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Tarsus Pharmaceuticals, Inc.Xdemvy | $12,537 | $744,643414 claims |
| AbbVieRestasis, Lumigan | $157 | $79,30292 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa | $56,547 | $21,88764 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 674 ophthalmology providers in Michigan.
Other ophthalmology in Birmingham
- Manjool ShahAnn Arbor$609K
- Gregory KatzYpsilanti$401K
- David ZacksAnn Arbor$177K
- Scott WesthouseGrand Rapids$138K
- Bret HughesDetroit$123K
- Pradeepa YoganathanDetroit$115K
- Jason MillerAnn Arbor$104K
- David TukelDearborn$91K
- Yannis PaulusAnn Arbor$85K
- Shilpa KodatiAnn Arbor$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.